These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32723676)

  • 1. Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.
    Simms KT; Yuill S; Killen J; Smith MA; Kulasingam S; de Kok IMCM; van Ballegooijen M; Burger EA; Regan C; Kim JJ; Canfell K
    Gynecol Oncol; 2020 Sep; 158(3):710-718. PubMed ID: 32723676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
    Rositch AF; Nowak RG; Gravitt PE
    Cancer; 2014 Jul; 120(13):2032-8. PubMed ID: 24821088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Beavis AL; Gravitt PE; Rositch AF
    Cancer; 2017 May; 123(6):1044-1050. PubMed ID: 28112816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales.
    Redburn JC; Murphy MF
    BJOG; 2001 Apr; 108(4):388-95. PubMed ID: 11305546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
    Yoo W; Kim S; Huh WK; Dilley S; Coughlin SS; Partridge EE; Chung Y; Dicks V; Lee JK; Bae S
    PLoS One; 2017; 12(2):e0172548. PubMed ID: 28234949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
    Islami F; Fedewa SA; Jemal A
    Prev Med; 2019 Jun; 123():316-323. PubMed ID: 31002830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of adjusting for hysterectomy prevalence on cervical cancer incidence rates and trends among women aged 30 years or older-United States, 2001-2019.
    Gopalani SV; Sawaya GF; Rositch AF; Dasari S; Thompson TD; Mix JM; Saraiya M
    Am J Epidemiol; 2024 Aug; 193(8):1097-1105. PubMed ID: 38583940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adjusted cancer-incidence rates (United States).
    Merrill RM; Feuer EJ
    Cancer Causes Control; 1996 Sep; 7(5):544-52. PubMed ID: 8877053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010.
    Stang A; Hawk H; Knowlton R; Gershman ST; Kuss O
    Ann Epidemiol; 2014 Nov; 24(11):849-54. PubMed ID: 25241148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999-2004.
    Wong CA; Jim MA; King J; Tom-Orme L; Henderson JA; Saraiya M; Richardson LC; Layne L; Suryaprasad A; Espey DK
    Cancer Causes Control; 2011 Dec; 22(12):1681-9. PubMed ID: 21984306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.
    Vaccarella S; Franceschi S; Zaridze D; Poljak M; Veerus P; Plummer M; Bray F
    Lancet Oncol; 2016 Oct; 17(10):1445-1452. PubMed ID: 27567054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States.
    Matsuo K; Mandelbaum RS; Klar M; Ciesielski KM; Matsushima K; Matsuzaki S; Roman LD; Wright JD
    Gynecol Oncol; 2021 Jul; 162(1):43-49. PubMed ID: 33992450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysterectomy and its impact on the calculated incidence of cervical cancer and screening coverage in Denmark.
    Lam JU; Lynge E; Njor SH; Rebolj M
    Acta Oncol; 2015; 54(8):1136-43. PubMed ID: 25800858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysterectomy trends in Australia, 2000-2001 to 2013-2014: joinpoint regression analysis.
    Wilson LF; Pandeya N; Mishra GD
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1170-1179. PubMed ID: 28627047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The temporal and age-dependent patterns of hysterectomy-corrected cervical cancer incidence rates in Denmark: a population-based cohort study.
    Hammer A; Kahlert J; Rositch A; Pedersen L; Gravitt P; Blaakaer J; Soegaard M
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):150-157. PubMed ID: 27861705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
    Jamison PM; Noone AM; Ries LA; Lee NC; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):233-41. PubMed ID: 23239812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hysterectomy on the age-specific incidence of cervical and uterine cancer in Germany and other countries.
    Stang A
    Eur J Public Health; 2013 Oct; 23(5):879-83. PubMed ID: 22711786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projected time to elimination of cervical cancer in the USA: a comparative modelling study.
    Burger EA; Smith MA; Killen J; Sy S; Simms KT; Canfell K; Kim JJ
    Lancet Public Health; 2020 Apr; 5(4):e213-e222. PubMed ID: 32057315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program.
    Pei J; Shu T; Wu C; Li M; Xu M; Jiang M; Zhu C
    Front Public Health; 2022; 10():998174. PubMed ID: 36684904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.